ACTIVE SITE-BLOCKED FACTORS VIIA AND IXA DIFFERENTIALLY INHIBIT FIBRIN FORMATION IN A HUMAN EX-VIVO THROMBOSIS MODEL

被引:51
作者
KIRCHHOFER, D
TSCHOPP, TB
BAUMGARTNER, HR
机构
[1] Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., Basel
[2] Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., CH-4002 Basel
关键词
TISSUE FACTOR; BLOOD PLATELETS; FACTOR VII; FACTOR IX; THROMBOSIS;
D O I
10.1161/01.ATV.15.8.1098
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of tissue factor/factor VIIa (FVIIa) and factor VIIIa/factor IXa (FVIIIa/FIXa) complexes in thrombus formation was examined in a human ex vivo blood flow system by use of active site-blocked FVIIa (FVIIai) and FIXa (FIXai) as selective inhibitors. Blood was drawn directly from the veins of volunteers into a mixing device where FVIIai and FIXai were mixed with flowing blood. The blood then entered parallel-plate chambers containing coverslips coated with hu man fibrillar collagen or tissue factor-expressing cell layers of tumor necrosis factor-alpha-stimulated human endothelial cells, human smooth muscle cells, and J82 cells. Exposure of stimulated endothelial cells to blood flowing at a venous shear rate of 65/s led to fibrin deposition, which was inhibited by infusion of FVIIai (IC50, 3 nmol/L), as quantified by microdensitometry of fibrin-stained coverslips. Whereas FIXai (600 nmol/L) was only a weak inhibitor, FVIIai (GO nmol/L) reduced fibrinopeptide A (FPA) plasma levels from 504+/-79 to 171+/-27 ng/mL and concomitantly inhibited platelet thrombus deposition. Similarly, experiments with smooth muscle cells and J82 cells showed that FVIIai but not FIXai efficiently reduced FPA levels. Conversely, with tissue factor-free collagen, which induces platelet-dependent fibrin formation, infusion of FIXai but not of FVIIai inhibited fibrin deposition (IC50, 8 nmol/L) and reduced FPA levels from 55+/-8 to 9+/-5 ng/mL. However, FIXai did not affect the number of platelet thrombi deposited on collagen. The results suggest that fibrin formation on tissue factor-expressing cellular surfaces is initiated by tissue factor/FVIIa-dependent direct activation of factor X, while on the tissue factor-free collagen surface, factor X activation and subsequent fibrin formation is dependent on the platelet FVIIIa/FIXa complex.
引用
收藏
页码:1098 / 1106
页数:9
相关论文
共 50 条
[11]  
DRAKE TA, 1993, AM J PATHOL, V142, P1458
[12]   BINDING OF COAGULATION FACTOR-IX AND FACTOR-X TO THE ENDOTHELIAL CELL-SURFACE [J].
HEIMARK, RL ;
SCHWARTZ, SM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 111 (02) :723-731
[13]  
HEMKER HC, 1983, BLOOD CELLS, V9, P303
[14]   ROLE OF FACTOR-VIII-VONWILLEBRAND FACTOR AND FIBRONECTIN IN THE INTERACTION OF PLATELETS IN FLOWING BLOOD WITH MONOMERIC AND FIBRILLAR HUMAN COLLAGEN TYPE-I AND TYPE-III [J].
HOUDIJK, WPM ;
SAKARIASSEN, KS ;
NIEVELSTEIN, PFEM ;
SIXMA, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (02) :531-540
[15]   CULTURE OF HUMAN ENDOTHELIAL CELLS DERIVED FROM UMBILICAL VEINS - IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGICAL CRITERIA [J].
JAFFE, EA ;
NACHMAN, RL ;
BECKER, CG ;
MINICK, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (11) :2745-2756
[16]   ANTITHROMBOTIC EFFECT OF A MONOCLONAL-ANTIBODY AGAINST TISSUE FACTOR IN A RABBIT MODEL OF PLATELET-MEDIATED ARTERIAL THROMBOSIS [J].
JANG, IK ;
GOLD, HK ;
LEINBACH, RC ;
FALLON, JT ;
COLLEN, D ;
WILCOX, JN .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (08) :948-954
[17]   RECONSTITUTED COLLAGEN IS NOT CAPABLE OF ACTIVATING FACTOR-XII BUT CAUSES INTRINSIC COAGULATION BY ACTIVATING PLATELETS [J].
KAWAMOTO, Y ;
KAIBARA, M .
BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (04) :371-379
[18]  
KIRCHHOFER D, 1993, BLOOD, V81, P2050
[19]   ENDOTHELIAL-CELLS STIMULATED WITH TUMOR-NECROSIS-FACTOR-ALPHA EXPRESS VARYING AMOUNTS OF TISSUE FACTOR RESULTING IN INHOMOGENOUS FIBRIN DEPOSITION IN A NATIVE BLOOD-FLOW SYSTEM - EFFECTS OF THROMBIN INHIBITORS [J].
KIRCHHOFER, D ;
TSCHOPP, TB ;
HADVARY, P ;
BAUMGARTNER, HR .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2073-2083
[20]  
KOUNS WC, 1992, J BIOL CHEM, V267, P18844